• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[抑郁症表型的个性化治疗:曲唑酮在伴失眠抑郁症中的作用]

[Personalized treatment of depression phenotypes: role of trazodone in depression with insomnia].

作者信息

Antonelli Incalzi Raffaele, Caraci Filippo, Cuomo Alessandro, Fagiolini Andrea, Ferini Strambi Luigi

机构信息

Dipartimento di Geriatria, Università Campus Bio-Medico, Roma.

Dipartimento di Scienze del Farmaco, Università di Catania, Catania - Oasi Institute for Research on Mental Retardation and Brain Aging (IRCCS), Troina, Italy.

出版信息

Riv Psichiatr. 2020 Nov-Dec;55(6):371-379. doi: 10.1708/3503.34896.

DOI:10.1708/3503.34896
PMID:33349731
Abstract

AIM

This paper completes a series of three manuscripts on the clinically relevant evidence of the use of trazodone in major depressive disorder. The first paper provided general clinical guidance on the use of trazodone in major depressive disorder. The second paper evaluated the different clinical scenarios in which trazodone prolonged-release or trazodone Contramid® once-a-day may be more indicated. This third and last paper evaluates the clinically relevant evidence about the use of trazodone in major depressive disorder (MDD) with insomnia.

METHODS

Medline and Cochrane Library searches were performed using the keywords 'trazodone' AND 'depression' AND 'insomnia', to identify the most relevant literature on the use of trazodone in patients with MDD and insomnia. European and the United States prescribing information was reviewed as well. More weight was given to the information that was deemed as most relevant for daily clinical practice.

RESULTS

Trazodone is an effective medication for patients with MDD and insomnia.

DISCUSSION

Trazodone is efficacious for the treatment of a broad array of depressive symptoms and is particularly useful for patients presenting with insomnia as one of the symptoms of depression.

CONCLUSIONS

Trazodone improves sleep and depression and is particularly helpful for patients whose symptoms of depression include insomnia.

摘要

目的

本文完成了关于曲唑酮在重度抑郁症中应用的临床相关证据的三篇系列文稿。第一篇文稿提供了曲唑酮在重度抑郁症中应用的一般临床指导。第二篇文稿评估了更适合使用曲唑酮缓释片或每日一次的曲唑酮控释片的不同临床情况。这第三篇也是最后一篇文稿评估了曲唑酮在伴有失眠的重度抑郁症(MDD)中应用的临床相关证据。

方法

使用关键词“曲唑酮”、“抑郁症”和“失眠”在Medline和Cochrane图书馆进行检索,以确定关于曲唑酮在MDD伴失眠患者中应用的最相关文献。还查阅了欧洲和美国的处方信息。对被认为与日常临床实践最相关的信息给予了更多权重。

结果

曲唑酮对MDD伴失眠患者是一种有效的药物。

讨论

曲唑酮对治疗多种抑郁症状有效,对以失眠作为抑郁症状之一的患者尤其有用。

结论

曲唑酮可改善睡眠和抑郁,对抑郁症状包括失眠的患者特别有帮助。

相似文献

1
[Personalized treatment of depression phenotypes: role of trazodone in depression with insomnia].[抑郁症表型的个性化治疗:曲唑酮在伴失眠抑郁症中的作用]
Riv Psichiatr. 2020 Nov-Dec;55(6):371-379. doi: 10.1708/3503.34896.
2
[Trazodone Contramid® in clinical practice: personalizing antidepressant intervention].[曲唑酮(Contramid®)在临床实践中的应用:个体化抗抑郁干预]
Riv Psichiatr. 2016 Jul-Aug;51(4):123-128. doi: 10.1708/2342.25112.
3
Clinical guidance for the use of trazodone in major depressive disorder and concomitant conditions: pharmacology and clinical practice.用于治疗重度抑郁症和伴随疾病的曲唑酮使用的临床指导:药理学和临床实践。
Riv Psichiatr. 2019 Jul-Aug;54(4):137-149. doi: 10.1708/3202.31796.
4
[Personalized medicine with extended-release trazodone and/or once-a-day trazodone: from research trials to clinical practice].[使用缓释曲唑酮和/或每日一次曲唑酮的个性化医疗:从研究试验到临床实践]
Riv Psichiatr. 2020 Sep-Oct;55(5):255-261. doi: 10.1708/3457.34457.
5
The efficacy and tolerability of once-daily controlled-release trazodone for depressed mood, anxiety, insomnia, and suicidality in major depressive disorder.每日一次的控释曲唑酮治疗重度抑郁症患者的情绪低落、焦虑、失眠及自杀倾向的疗效与耐受性
Psychopharmacol Bull. 2009;42(4):5-22.
6
Confirmation of the neurophysiologically predicted therapeutic effects of trazodone on its target symptoms depression, anxiety and insomnia by postmarketing clinical studies with a controlled-release formulation in depressed outpatients.通过对抑郁症门诊患者使用缓释制剂进行上市后临床研究,证实曲唑酮对其目标症状(抑郁、焦虑和失眠)具有神经生理学预测的治疗效果。
Neuropsychobiology. 2003;48(4):194-208. doi: 10.1159/000074638.
7
[Serotonin neurotrasmission and treatment options for depression].[血清素神经传递与抑郁症的治疗选择]
Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(11):174-177. doi: 10.17116/jnevro2017117111174-177.
8
Rethinking the role of trazodone in the different depressive dimensions.重新思考曲唑酮在不同抑郁维度中的作用。
Expert Rev Neurother. 2024 Jul;24(7):619-632. doi: 10.1080/14737175.2024.2363843. Epub 2024 Jun 17.
9
Rediscovering trazodone for the treatment of major depressive disorder.重新发现曲唑酮治疗重度抑郁症。
CNS Drugs. 2012 Dec;26(12):1033-49. doi: 10.1007/s40263-012-0010-5.
10
[Current treatment of depression and agitation in the elderly -- clinical use of trazodone].[老年人抑郁症和激越的当前治疗——曲唑酮的临床应用]
Neuropsychopharmacol Hung. 2013 Sep;15(3):147-55.

引用本文的文献

1
Advancing Antidepressive Agents: Drug Discovery and Polymer-Based Drug Delivery Systems for Improved Treatment Outcome.抗抑郁药物的进展:药物发现与基于聚合物的药物递送系统以改善治疗效果。
Biomedicines. 2025 Apr 29;13(5):1081. doi: 10.3390/biomedicines13051081.
2
Forensic Aspects of a Fatal Intoxication Involving Acetaminophen, Citalopram and Trazodone: A Case Report.一例涉及对乙酰氨基酚、西酞普兰和曲唑酮的致命中毒的法医学问题:病例报告
Toxics. 2022 Aug 22;10(8):486. doi: 10.3390/toxics10080486.
3
Trazodone Levels in Maternal Serum, Cord Blood, Breast Milk, and Neonatal Serum.
母体血清、脐血、母乳和新生儿血清中的曲唑酮水平。
Breastfeed Med. 2021 Nov;16(11):922-925. doi: 10.1089/bfm.2021.0191. Epub 2021 Aug 3.